News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
FDA
Merck & Co., Inc. Says FDA Approves New AIDS Treatment
October 12, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
WASHINGTON (Reuters) - U.S. regulators approved a new AIDS treatment made by Merck & Co, the first in a new class of drugs aimed at preventing replication of the virus, Merck said on Friday.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
Merck & Co.
Food and Drug Administration (FDA)
MORE ON THIS TOPIC
Regulatory
FDA alleges ‘manipulated’ data supported approval of Amgen’s autoimmune drug
April 28, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
UCSF, Par Health hit with FDA warning letters for environmental monitoring issues
April 27, 2026
·
2 min read
·
Nick Paul Taylor
Psychedelics
FDA awards priority vouchers to 3 undisclosed companies for investigational psychedelics
April 24, 2026
·
3 min read
·
Heather McKenzie
Complete response letters
Unnamed pharma files citizen petition targeting FDA’s trove of rejection letters
April 23, 2026
·
2 min read
·
Tristan Manalac
